Policy paper
UK-US arrangement on pharmaceutical trade and pricing
Shared UK and US commitments to improve access to medicines, support pharmaceutical innovation and grow trade in the life sciences sector.
Documents
Details
This document records the preliminary understanding reached on 1 December 2025, between the United States of America and the United Kingdom on pharmaceutical trade and pricing. It builds on the US-UK Economic Prosperity Deal announced on 8 May 2025.
The 2 governments have agreed to work together to:
- ensure all countries contribute fairly to the cost of pharmaceutical innovation
- strengthen both countries’ pharmaceutical supply chains
- improve the operating environment for pharmaceutical companies in the UK
- get innovative medicines to patients more quickly
- grow mutually beneficial trade to support jobs and economic growth
Updates to this page
Published 2 April 2026